Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome

Pediatr Int. 2015 Apr;57(2):e39-41. doi: 10.1111/ped.12603.

Abstract

There are few reports on successful high-dose spironolactone treatment of refractory protein-losing enteropathy (PLE) caused by Fontan procedure. We report successful diuretics treatment with spironolactone and furosemide at standard dose, of refractory PLE in a patient with Noonan syndrome and repaired congenital heart disease. This is the first successful application of diuretics treatment in a patient with refractory PLE without Fontan procedure. This case illustrates that diuretics treatment can be the first-line treatment of PLE regardless of the causative physiology, and can be effective in refractory PLE with Noonan syndrome.

Keywords: Noonan syndrome; diuretic; protein-losing enteropathy; venous pressure.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Diuretics / therapeutic use*
  • Female
  • Fontan Procedure / adverse effects
  • Furosemide / therapeutic use*
  • Heart Defects, Congenital / surgery
  • Humans
  • Noonan Syndrome / complications*
  • Protein-Losing Enteropathies / drug therapy*
  • Protein-Losing Enteropathies / etiology
  • Spironolactone / therapeutic use*

Substances

  • Diuretics
  • Spironolactone
  • Furosemide